Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Semaglutide 2.4 mg (Wegovy) is a glucagon-like peptide-1 (GLP-1) receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study
Long-Acting Amylin Agonist AZD6234 AZD6234 is a novel long-acting selective AMY3R agonist developed by AstraZeneca for SC administration, and is currently in phase 2 testing [114]
Specifications: Unit Size: 10mg (lyophilized powder, single vial) Molecular Formula: CHNO Molecular Weight: ~1419.5 Da Form: Lyophilized powder Storage: Store lyophilized peptide at 2C8C in a cool, dark place
US$ 23.28
US$ 27.26
US$ 26.49
US$ 24.51
US$ 20.10
US$ 22.00
